Introduction Breast cancer is the most common type of cancer in women. Neoadjuvant chemotherapy (NAC) has become the initial treatment for locally advanced breast cancer.1 Its use has expanded after the recommendation for using NAC to T1c-N0 patients with human epidermal growth factor receptor 2 (HER2) positive and triple negative in the 2023 NCCN guideline. […]
No takes yet. Share an insight, caveat, or question.
Sağlam et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: